Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Schizophrenia

Free Subscription 09.05.2022 1 Biol Psychiatry 1 J Clin Psychopharmacol 6 Mol Psychiatry 1 Pharmacopsychiatry 1 PLoS Comput Biol 3 Psychiatry Res 1 Psychol Med 1 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biol Psychiatry

1. ROESKE MJ, Lyu I, McHugo M, Blackford JU, et al
   Incomplete Hippocampal Inversion: A Neurodevelopmental Mechanism for Hippocampal Shape Deformation in Schizophrenia.
   Biol Psychiatry. 2022 Feb 23. pii: S0006-3223(22)01041.
   PubMed         Abstract available
   
   

   
   J Clin Psychopharmacol

2. GALLAGHER KE, Funaro MC, Woods SW
   Prescription Stimulants and the Risk of Psychosis: A Systematic Review of Observational Studies.
   J Clin Psychopharmacol. 2022;42:308-314.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

3. FASS DM, Lewis MC, Ahmad R, Szucs MJ, et al
   Brain-specific deletion of GIT1 impairs cognition and alters phosphorylation of synaptic protein networks implicated in schizophrenia susceptibility.
   Mol Psychiatry. 2022 May 3. pii: 10.1038/s41380-022-01557.
   PubMed         Abstract available
   
   
4. SAARINEN A, Lyytikainen LP, Hietala J, Dobewall H, et al
   Magical thinking in individuals with high polygenic risk for schizophrenia but no non-affective psychoses-a general population study.
   Mol Psychiatry. 2022 May 3. pii: 10.1038/s41380-022-01581.
   PubMed         Abstract available
   
   
5. KOMATSU H, Onoguchi G, Jerotic S, Kanahara N, et al
   Retinal layers and associated clinical factors in schizophrenia spectrum disorders: a systematic review and meta-analysis.
   Mol Psychiatry. 2022 May 2. pii: 10.1038/s41380-022-01591.
   PubMed         Abstract available
   
   
6. OLISLAGERS M, Rademaker K, Adan RAH, Lin BD, et al
   Comprehensive analyses of RNA-seq and genome-wide data point to enrichment of neuronal cell type subsets in neuropsychiatric disorders.
   Mol Psychiatry. 2022;27:947-955.
   PubMed         Abstract available
   
   
7. KIRSCHNER M, Hodzic-Santor B, Antoniades M, Nenadic I, et al
   Cortical and subcortical neuroanatomical signatures of schizotypy in 3004 individuals assessed in a worldwide ENIGMA study.
   Mol Psychiatry. 2022;27:1167-1176.
   PubMed         Abstract available
   
   
8. NAIR PC, Miners JO, McKinnon RA, Langmead CJ, et al
   Binding of SEP-363856 within TAAR1 and the 5HT1A receptor: implications for the design of novel antipsychotic drugs.
   Mol Psychiatry. 2022;27:88-94.
   PubMed         Abstract available
   
   

   
   Pharmacopsychiatry

9. MIURA G, Tanaka K, Kemuriyama T, Misawa F, et al
   Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review.
   Pharmacopsychiatry. 2022 May 5. doi: 10.1055/a-1811-7318.
   PubMed         Abstract available
   
   

   
   PLoS Comput Biol

10. GRAVINA A, Wilson JL, Bacciu D, Grimes KJ, et al
    Controlling astrocyte-mediated synaptic pruning signals for schizophrenia drug repurposing with deep graph networks.
    PLoS Comput Biol. 2022;18:e1009531.
    PubMed         Abstract available
    
    

    
    Psychiatry Res

11. MARTINS PS, Caldas F, Oliveira C, Mota J, et al
    A 10-year mirror-image study of effectiveness and cost of long-acting paliperidone palmitate injectable in patients with schizophrenia or schizoaffective disorder.
    Psychiatry Res. 2022;312:114581.
    PubMed         Abstract available
    
    
12. XU Y, Cai Z, Fang C, Zheng J, et al
    Impact of aerobic exercise on cognitive function in patients with schizophrenia during daily care: A meta-analysis.
    Psychiatry Res. 2022;312:114560.
    PubMed         Abstract available
    
    
13. GONZALEZ-RODRIGUEZ A, Monreal JA, Porras-Segovia A, Cervilla JA, et al
    Psychometric instruments for the assessment of depressive symptoms in patients with delusional disorder: A systematic review.
    Psychiatry Res. 2022;310:114435.
    PubMed         Abstract available
    
    

    
    Psychol Med

14. TERMORSHUIZEN F, Selten JP
    Risk of psychosis among migrants to the Netherlands by time since arrival.
    Psychol Med. 2022 May 5:1-10. doi: 10.1017/S0033291722001192.
    PubMed         Abstract available
    
    

    
    Schizophr Res

15. MALHI GS, Bell E
    Reframing schizophrenia: Altering our perceptions?
    Schizophr Res. 2022;244:8-9.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: